| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.03 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |